• 1
    Koch M, Banys P. Liver transplantation and opioid dependence. JAMA 2001; 285:10561058.
  • 2
    Gordon MJ, White R, Matas AJ, Tellis VA, Glicklich D, Quinn T, et al. Renal transplantation in patients with a history of heroin abuse. Transplantation 1986; 42:556557.
  • 3
    Stevens J, Callender CO, Simon J, Dillard P, Yeager CL. Renal transplantation in heroin addicts. Surg Gynecol Obstet 1983; 156:651655.
  • 4
    Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999; 107:2S9S.
  • 5
    Substance Abuse and Mental Health Services Administration. Summary of findings from the 2000 National Household Survey on Drug Abuse. Office of Applied Studies, NHSDA Series H-13, DHHS Publication No. (SMA)01–3549. Rockville, MD, 2001.
  • 6
    NIH Consensus Statement. Available at: Accessed July 9, 2002.
  • 7
    Chetwynd J, Brunton C, Blank M, Plumridge E, Baldwin D. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme. N Z Med J 1995; 108:364366.
  • 8
    Jonsen AR. Ethical issues in organ transplantation. In: VeatchRM, ed. Medical Ethics. 2nd ed. Sudbury, MA: Jones and Bartlett; 1997:239274.
  • 9
    Levenson JL, Olbrisch ME. Psychosocial evaluation of organ transplant candidates. A comparative survey of process, criteria, and outcomes in heart, liver, and kidney transplantation. Psychosomatics 1993; 34:314323.
  • 10
    Glannon W. Responsibility, alcoholism, and liver transplantation. J Med Philos 1998; 23:3149.
  • 11
    Martens W. Do alcoholic liver transplantation candidates merit lower medical priority than non-alcoholic candidates? Transpl Int 2001; 14:170175.
  • 12
    Musto DF. The American Disease: Origins of Narcotic Control. New York; Oxford: 1987.
  • 13
    Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA 2000; 283:13031310.
  • 14
    Platt JJ. Heroin Addiction. Malabar, Florida: Robert E. Krieger Publishing Company, 1986.
  • 15
    Gottheil E, Sterling RC, Weinstein SP. Diminished illicit drug use as a consequence of long-term methadone maintenance. J Addict Dis 1993; 12:4557.
  • 16
    Starzl TE, Van Thiel D, Tzakis AG, Iwatsuki S, Todo S, Marsh JW, et al. Orthotopic liver transplantation for alcoholic cirrhosis. JAMA 1988; 260:25422544.
  • 17
    Keeffe EB. Assessment of the alcoholic patient for liver transplantation: Comorbidity, outcome, and recidivism. Liver Transpl Surg 1996; 2(Suppl 1):1220.
  • 18
    Hoofnagle JH, Kresina T, Fuller RK, Lake JR, Lucey MR, Sorrell MF, et al. Liver transplantation for alcoholic liver disease: Executive statement and recommendations. Summary of a National Institutes of Health workshop held December 6–7, 1996, Bethesda, Maryland. Liver Transpl Surg 1997; 3:347350.
  • 19
    Belle SH, Detre KM, Beringer KC. The relationship between outcome of liver transplantation and experience in new centers. Liver Transpl Surg 1995; 1:347353.
  • 20
    Public Policy of ASAM, Methadone Treatment. Adopted By ASAM Board of Directors 4/25/90, Amended 11/11/90, Amended 10/5/91. Available at: Accessed July 9, 2002.
  • 21
    NIH Consensus Statement. Effective Medical Treatment of Opiate Addiction, 1997;15, No. 6, Nov 17–19. Available at: Accessed July 9, 2002.